Evaluation of Physiologically Based Pharmacokinetic Models in Risk Assessment: An Example with Perchloroethylene
- 1 January 2005
- journal article
- review article
- Published by Taylor & Francis in Critical Reviews in Toxicology
- Vol. 35 (5) , 413-433
- https://doi.org/10.1080/10408440590931994
Abstract
One of the more problematic aspects of the application of physiologically based pharmacokinetic (PBPK) models in risk assessment is the question of whether the model has been adequately validated to provide confidence in the dose metrics calculated with it. A number of PBPK models have been developed for perchloroethylene (PCE), differing primarily in the parameters estimated for metabolism. All of the models provide reasonably accurate simulations of selected kinetic data for PCE in mice and humans and could thus be considered to be “validated” to some extent. However, quantitative estimates of PCE cancer risk are critically dependent on the prediction of the rate of metabolism at low environmental exposures. Recent data on the urinary excretion of trichloroacetic acid (TCA), the major metabolite of PCE, for human subjects exposed to lower concentrations than those used in previous studies, make it possible to compare the high- to low-dose extrapolation capability of the various published human models. The model of Gearhart et al., which is the only model to include a description of TCA kinetics, provided the closest predictions of the urinary excretion observed in these low-concentration exposures. Other models overestimated metabolite excretion in this study by 5- to 15-fold. A systematic discrepancy between model predictions and experimental data for the time course of the urinary excretion of TCA suggested a contribution from TCA formed by metabolism of PCE in the kidney and excreted directly into the urine. A modification of the model of Gearhart et al. to include metabolism of PCE to TCA in the kidney at 10% of the capacity of the liver, with direct excretion of the TCA formed in the kidney into the urine, markedly improved agreement with the experimental time-course data, without altering predictions of liver metabolism. This case study with PCE demonstrates the danger of relying on parent chemical kinetic data to validate a model that will be used for the prediction of metabolism.Keywords
This publication has 86 references indexed in Scilit:
- A Physiologically Based Pharmacokinetic Model for Trichloroethylene in the Male Long-Evans RatToxicological Sciences, 2002
- Biotransformation of Perchloroethene: Dose-Dependent Excretion of Trichloroacetic Acid, Dichloroacetic Acid, andN-acetyl-S-(trichlorovinyl)-l-Cysteine in Rats and Humans after InhalationToxicology and Applied Pharmacology, 1998
- Incorporating biological information in quantitative risk assessment: an example with methylene chlorideToxicology, 1995
- The application of physiologically based pharmacokinetic modeling in human health risk assessment of hazardous substancesToxicology Letters, 1995
- Applying Simulation Modeling to Problems in Toxicology and Risk Assessment: A Short PerspectiveToxicology and Applied Pharmacology, 1995
- Sensitivity of Physiologically Based Pharmacokinetic Models to Variation in Model Parameters: Methylene ChlorideRisk Analysis, 1994
- Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE)Toxicology Letters, 1993
- Evaluating the Risk of Liver Cancer in Humans Exposed to Trichloroethylene Using Physiological ModelsRisk Analysis, 1993
- Physiologically based pharmacokinetics and the risk assessment process for methylene chlorideToxicology and Applied Pharmacology, 1987
- Risk Assessment Extrapolations and Physiological ModelingToxicology and Industrial Health, 1985